Review on NAPA, with data on DNA/RNA, on the protein encoded and where the gene is implicated.
DNA/RNA

Description
The NAPA gene spans 27,61 kb on chromosome 19q13 and consists of 11 exons and 10 introns ( fig.  1 ) with an open reading frame of 1839 bp. The NAPA promoter has not been functionally explored.
Transcription
The predominant transcript variant (1) of the NAPA gene encodes a functional protein of 295 amino acids. The second transcript of 1521 bp is predicted to encode a 256 amino acid protein. This variant (2) uses an alternate splice site in the 3' terminal exon, compared to variant 1. This variant is represented as non-coding because the use of the alternate splice site renders the resulting transcript a candidate for nonsensemediated mRNA decay (NMD). The third transcript, variant (3), is 1668 bp. Variant (3) lacks two consecutive internal exons, compared to variant 1. During the initial docking step, v-SNARE and t-SNARE bind creating a complex that drives pore formation and fusion of the two opposing membranes. After the fusion step, NAPA is recruited to the cys-SNARE complex allowing NSF binding. Next the ATPase activity of NSF and conformational changes of both NSF and NAPA disassemble the cys-SNARE complex, and release its components for recycling in subsequent fusion events.
This variant is also represented as non-coding because the use of the 5'-most expected translational start codon, as used in variant 1, also makes this transcript a candidate for NMD. Additionally, 2 alternative transcribed variants are predicted to exist via the automatic annotation program, Havana. However, these predicted transcripts need to be experimentally confirmed.
Pseudogene
None discovered.
Protein
Description
The sequence of the predicted 295-amino acid; 33233 Da human protein encoded by NAPA shares 37%, 60%, and 81% identity with sequences in yeast (Sacharomyces cerevisiae), Drosophila melanogaster, and zebrafish (Danio rerio). NAPA belongs to a protein family comprised of, in higher eukaryotes, three homologues named NAPA, soluble NSF attachment protein beta (NAPB), and soluble NSF attachment protein gamma (NAPG) (Clary et al., 1990) . Amino acid sequence comparison of bovine proteins show that NAPA and NAPB are most related to each other with 83% amino acid identity (Whiteheart et al., 1993) . In contrast, NAPA and NAPG have only about 25% sequence identity. Structural information is available for the yeast homolog of NAPA, Sec17 (Rice and Brunger, 1999) , and zebrafish NAPG (Bitto et al., 2008) . Both homologs represent elongated proteins comprised of an extended twisted sheet of α-helical hairpins and a helicalbundle domain at the carboxy-terminal end.
Expression
NAPA is ubiquitously expressed in various mammalian cells and tissues. In mouse tissues, its expression level is highest in the brain, spleen, and testis (Whiteheart et al., 1993) . Data from the human gene atlas has shown that NAPA is expressed at the highest level in heart, liver, lung, and placenta. Regulation of NAPA expression remains unexplored. One recent report demonstrated decreased protein levels of NAPA in brain synaptosomes of rats subjected to oxidative stress (Kaneai et al., 2013) .
Localisation
In polarized epithelial cells such as alveolar type II cells, T84, and SK-CO15 human colonic epithelial cells NAPA predominantly localizes in the plasma membrane with significant enrichment at the apical junctional complex (Abonyo et al., 2003; Naydenov et al., 2012a) . By contrast, in contact-naïve epithelial cells, NAPA accumulates in the perinuclear intracellular compartment that resembles the Golgi complex (Naydenov et al., 2012a) .
Function
One of the most-studied intracellular functions of NAPA involves regulation of NSF-dependent vesicle fusion (Andreeva et al., 2006) . According to the so-called "SNARE (soluble NSF attachment protein receptor) hypothesis" vesicle fusion is driven by specific associations of complementary SNARE proteins residing on the vesicle (vSNAREs) and target (t-SNAREs) membranes (Chen and Scheller, 2001) . These proteins form a core SNARE complex consisting of a parallel fourhelix bundle. This complex drives the opposing membranes to a close apposition, and subsequently to a complete fusion ( fig. 2) . Eukaryotic cells use an evolutionarily-conserved mechanism to disassemble and recycle the cys-SNARE complex that is formed after the fusion of two membranes (Barnard et al., 1997) . This mechanism involves a hexameric ATPase, NSF, and its adaptor protein, NAPA (Vivona et al., 2013; Wilson et al., 1992; Winter et al., 2009) . NAPA interacts with the SNARE complex, recruits NSF, stimulates NSF activity, and transduces a conformational change of NSF to drive SNARE disassembly ( fig. 2) . NAPA was implicated in the regulation of numerous trafficking/fusion events in different cellular compartments (Andreeva et al., 2006) . Examples of this regulation include ER-Golgi transport, intraGolgi vesicle fusion, trafficking from the transGolgi network to the plasma membrane, neuromediator exocytosis, and synaptic vesicle fusion (Barnard et al., 1997; Burgalossi et al., 2010; Clary et al., 1990; Low et al., 1998; Peter et al., 1998; Xu et al., 2002) . Interestingly, recent studies discovered several NSF-independent activities of NAPA. These activities involve assembly of epithelial junctions (Andreeva et al., 2005; Naydenov et al., 2012a) , suppression of cell apoptosis (Naydenov et al., 2012b; Wu and Chao, 2010) , and autophagy (Naydenov et al., 2012c) , as well as regulation of store-operated calcium entry (Miao et al., 2013) . Such NSF-independent functions are likely to depend on NAPA interactions with different binding partners. For example, NAPA may suppress apoptosis due to its binding to the ERresident, pro-apoptotic protein BNIP1 (Nakajima et al., 2004) . Furthermore, NAPA-dependent regulation of autophagy can be mediated by its ability to interact and dephosphorylate AMPactivated protein kinase (Wang and Brautigan, 2013) .
Mutations
Note A missense G to A transition that leads to a change from methionine to isoleucine (M105I) has been detected in mice (Chae et al., 2004; Hong et al., 2004) . This mutation leads to the appearance of the socalled hyh (hydrocephalus with hop gait) phenotype and also impairs acrosomal exocytosis in sperm (Bátiz et al., 2009 ). Other mutations have not been found associated with this gene potentially because of the multiple roles of NAPA in critical cellular functions which would prevent survival of cells with dysfunctional NAPA mutations.
Implicated in
Colorectal cancer
Note A study utilizing patients with small undifferentiated colorectal cancer revealed a significant increase of NAPA immunoreactivity in cancer cells that correlated with a more aggressive course of the disease (Grabowski et al., 2002) .
Down syndrome
Note
One study has analyzed expression of NAPA protein in fetal cortex samples of patients with Down Syndrome. The study reported a significant decrease in NAPA expression compared to control samples that correlated with deterioration of the neuronal dendritic tree (Weitzdoerfer et al., 2001) . Another study demonstrated a loss of NAPA homolog, NAPB, in brain specimens of adult patients with Down syndrome (Yoo et al., 2001 ).
Huntington's disease
Note Marked elevation of NAPA expression was observed by Western blotting of hippocampus samples from patients with Huntington's diseases as compared to age-matched controls (Morton et al., 2001) .
Atopic dermatitis
Note A proteomic analysis of peripheral blood leukocytes demonstrated significant downregulation of NAPA expression in patients with atopic dermatitis as compared to control subjects (Kim et al., 2008) . This decrease was validated by Western blotting analysis and NAPA level was suggested as a possible biomarker for the disease.
To be noted
